Oura Omnichannel Metabolic Pivot

Diving deeper into

$1B/year Finnish MAHA wearable

Document
went omnichannel into Target and Amazon, and moved into metabolic health via a $75M strategic investment from Dexcom.
Analyzed 6 sources

This was the moment Oura stopped behaving like a niche wellness gadget and started building a scaled consumer health platform. Target and Amazon made the ring easy to discover and buy where mainstream shoppers already browse, while Dexcom pulled Oura beyond sleep and recovery into glucose aware coaching, where the app can connect meals, stress, sleep, movement, and blood sugar into one daily habit loop.

  • Retail changed the top of funnel. By April 2024 Oura had expanded into Amazon and Target, adding mass distribution on top of direct sales and Best Buy. That helped drive 1.3M ring sales in 2024, with hardware reaching about $390M of revenue and subscriptions adding about $110M from 2M paying members.
  • The Dexcom deal changed what the product could do. Dexcom made a separate $75M strategic investment alongside Oura's Series D, and the partnership lets glucose data flow into the Oura app next to sleep, activity, stress, and meal logging, so the app can show how a specific lunch or bad night of sleep affects metabolic signals.
  • That puts Oura closer to a broader preventive health stack than a single purpose wearable. Whoop still centers on training strain and recovery, while Oura has widened into cycle tracking, stress, heart health, and now metabolic health, making the ring a front door into adjacent services and data partnerships.

The next phase is turning retail reach and new sensors into a larger health wallet share. As Oura adds more clinical and behavior change features around glucose, labs, and women's health, the ring becomes less like jewelry with an app and more like a lightweight operating system for everyday health decisions.